BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 11507326)

  • 1. Oxidants and antioxidants in atherosclerosis.
    Mashima R; Witting PK; Stocker R
    Curr Opin Lipidol; 2001 Aug; 12(4):411-8. PubMed ID: 11507326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tocopherol-mediated peroxidation of lipoproteins: implications for vitamin E as a potential antiatherogenic supplement.
    Upston JM; Terentis AC; Stocker R
    FASEB J; 1999 Jun; 13(9):977-94. PubMed ID: 10336881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extent of antioxidant protection of plasma LDL is not a predictor of the antiatherogenic effect of antioxidants.
    Fruebis J; Bird DA; Pattison J; Palinski W
    J Lipid Res; 1997 Dec; 38(12):2455-64. PubMed ID: 9458269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of VCAM-1 expression in the arterial wall is shared by structurally different antioxidants that reduce early atherosclerosis in NZW rabbits.
    Fruebis J; Silvestre M; Shelton D; Napoli C; Palinski W
    J Lipid Res; 1999 Nov; 40(11):1958-66. PubMed ID: 10552999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antioxidants decreases the intensification of low density lipoprotein in vivo peroxidation during therapy with statins.
    Lankin VZ; Tikhaze AK; Kukharchuk VV; Konovalova GG; Pisarenko OI; Kaminnyi AI; Shumaev KB; Belenkov YN
    Mol Cell Biochem; 2003 Jul; 249(1-2):129-40. PubMed ID: 12956408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of antioxidants on the oxidative susceptibility of low-density lipoprotein.
    Hirano R; Kondo K; Iwamoto T; Igarashi O; Itakura H
    J Nutr Sci Vitaminol (Tokyo); 1997 Aug; 43(4):435-44. PubMed ID: 9328862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultraviolet-treated lipoproteins as a model system for the study of the biological effects of lipid peroxides on cultured cells. III. The protective effect of antioxidants (probucol, catechin, vitamin E) against the cytotoxicity of oxidized LDL occurs in two different ways.
    Negre-Salvayre A; Alomar Y; Troly M; Salvayre R
    Biochim Biophys Acta; 1991 Jun; 1096(4):291-300. PubMed ID: 2065102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized low density lipoprotein hypothesis.
    Heinecke JW
    Atherosclerosis; 1998 Nov; 141(1):1-15. PubMed ID: 9863534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The molecular action of alpha-tocopherol in lipoprotein lipid peroxidation. Pro- and antioxidant activity of vitamin E in complex heterogeneous lipid emulsions.
    Witting PK; Upston JM; Stocker R
    Subcell Biochem; 1998; 30():345-90. PubMed ID: 9932522
    [No Abstract]   [Full Text] [Related]  

  • 10. Molecular action of vitamin E in lipoprotein oxidation: implications for atherosclerosis.
    Thomas SR; Stocker R
    Free Radic Biol Med; 2000 Jun; 28(12):1795-805. PubMed ID: 10946221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage foam cell formation during early atherogenesis is determined by the balance between pro-oxidants and anti-oxidants in arterial cells and blood lipoproteins.
    Aviram M
    Antioxid Redox Signal; 1999; 1(4):585-94. PubMed ID: 11233155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Requirement for, promotion, or inhibition by alpha-tocopherol of radical-induced initiation of plasma lipoprotein lipid peroxidation.
    Neuzil J; Thomas SR; Stocker R
    Free Radic Biol Med; 1997; 22(1-2):57-71. PubMed ID: 8958130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidized low-density lipoprotein and atherosclerosis.
    Devaraj S; Jialal I
    Int J Clin Lab Res; 1996; 26(3):178-84. PubMed ID: 8905449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of oxidized lipoproteins in atherogenesis.
    Berliner JA; Heinecke JW
    Free Radic Biol Med; 1996; 20(5):707-27. PubMed ID: 8721615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of lipid peroxidation, antioxidants and pro-oxidants in atherosclerosis.
    Salonen JT
    Acta Cardiol; 1993; 48(5):457-9. PubMed ID: 8284977
    [No Abstract]   [Full Text] [Related]  

  • 16. Probucol as an antioxidant and antiatherogenic drug.
    Kuzuya M; Kuzuya F
    Free Radic Biol Med; 1993 Jan; 14(1):67-77. PubMed ID: 8454225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary radicals derived from chloramines of apolipoprotein B-100 contribute to HOCl-induced lipid peroxidation of low-density lipoproteins.
    Hazell LJ; Davies MJ; Stocker R
    Biochem J; 1999 May; 339 ( Pt 3)(Pt 3):489-95. PubMed ID: 10215584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidants and antioxidants in atherogenesis. An appraisal.
    Parthasarathy S; Santanam N; Ramachandran S; Meilhac O
    J Lipid Res; 1999 Dec; 40(12):2143-57. PubMed ID: 10588940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin E and atherosclerosis: beyond prevention of LDL oxidation.
    Meydani M
    J Nutr; 2001 Feb; 131(2):366S-8S. PubMed ID: 11160562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Oxidized lipoproteins and atherogenesis].
    Jürgens G; Chen Q; Ledinski G; Kager G; Hammer A; Esterbauer H
    Acta Med Austriaca; 1993; 20(4):85-9. PubMed ID: 8237282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.